22 Mar Experts call for TGA-approved rapid COVID-19 tests to be used in Australia
Our MD, John Kelly spoke to ABC News about the need for TGA-approved rapid COVID-19 tests to be used in Australia. Read Article Here...
22 Mar Escrow: Here’s why it’s worth watching and which stocks are releasing shares soon
Stockhead lists Atomo Diagnostics as a stock to watch. Read Article Here...
22 Mar The Atomo Diagnostics (ASX:AT1) share price is popping 7% today
The Motley Fool talks about Atomo Diagnostics’ share price rise. Read Article Here...
19 Mar Harvard Universities COVID-19 Screening Program
Harvard has begun to welcome back a limited number of students, faculty, academic personnel, and staff to our campus as conditions allow. They have deployed several strategies—including high-frequency viral testing for all community members who are authorized to have a regular presence on campus—to help...
19 Mar MIT’s COVID-19 Screening Program
An effective testing program is a crucial part of minimizing the spread of COVID-19 in a community, and testing innovations adopted by MIT are helping in-person activities to resume on campus. Read Article Here...
19 Mar University of Illinois COVID-19 Screening Program
An effective testing program is a crucial part of minimizing the spread of COVID-19 in a community, and testing innovations developed by the University of Illinois Urbana-Champaign are helping in-person activities to resume on campus. Read Article Here...
19 Mar Yale Universities COVID-19 Screening Program
Yale’s COVID-19 Screening Program consists of two components: testing and contact tracing. The program was designed to reduce the risk of outbreaks on campus and in the New Haven community, based on epidemiologic models and the best available data. Free viral testing is available to all...
19 Mar USA Universities COVID-19 Testing Strategies
Colleges are planning a wide range of COVID-19 testing strategies, ranging from frequent universal testing to no campus-based testing at all. Variation of approaches raises questions about equity. Different colleges are planning a wide range of COVID-19 testing approaches this fall. Some are planning on twice-weekly...
26 Feb While we wait for a COVID-19 vaccine, rapid tests could help keep life near to normal
It’s a sign of how well Australia has handled the coronavirus pandemic that a single positive case in the community will make national headlines, while in many other countries thousands of people are dying from the disease every day. Our hotel quarantine system for returned travellers...
19 Feb New study identifies top-performing point-of-care COVID-19 tests
Researchers at NSF International and Novateur Ventures screen rapid-detection COVID-19 tests for clinical sensitivity/specificity, limit of detection and time to results After screening more than 1,100 independently assessed, point-of-care COVID-19 tests, researchers at NSF International and Novateur Ventures have identified 5 direct (antigen/RNA) tests for detection...
11 Feb Employers sign up to rapid testing to protect workforce.
Dozens of public and private sector employers are now offering rapid testing to those without symptoms. Businesses and public sector organisations are joining a government scheme to test workers without symptoms who cannot work from home. Around 1 in 3 people who have coronavirus have no symptoms...
11 Feb Major banks worldwide have launched COVID-19 testing programs.
Big banks, including Deutsche Bank and Bank of America, are testing employees for COVID-19 before they step into the office. Some banks are offering their staff lab-based PCR tests, which are considered the most accurate way of detecting coronavirus, but they can cost around $US100 to...
29 Jan Atomo Diagnostics (ASX:AT1) posts 709% boost in quarterly cash receipts
The Motley Fool covers Atomo’s December quarterly report and how the company is positioning itself for growth in 2021. Read Article Here ...
29 Jan Atomo Diagnostics (ASX:AT1) ends Q2 FY21 with $24.7M in cash
The Market Herald reports on Atomo’s positive December 2020 quarterly report. Read Article Here ...
11 Nov Ausbiz: The Strawman Classic Week 3 – The double CEO special (AT1, TNT)
Our MD John Kelly sat down with Ausbiz to talk about Atomo’s strong growth, our solid progress with commercialising our rapid diagnostics tests and securing licensing deals with partners. Watch the interview here ...
04 Nov TGA approves Atomo’s rapid antigen COVID-19 test
Atomo was featured in a recent article by Biotech Dispatch regarding the TGA approval of Atomo’s rapid antigen COVID-19 test. Read Article Here ...
04 Nov WA and Queensland Borders Start to Come Down
As WA and QLD take first steps to reopen borders, our CEO, John Kelly was asked to comment in the Australian Financial Review on how an antigen / antibody testing combo could help Australia to open up with more confidence. Read Article Here ...
29 Oct Atomo’s 15 minute COVID test gets its second key nod
Our MD, John Kelly was interviewed by Ausbiz about TGA approval for our COVID-19 rapid antigen test. Watch the Interview Here ...
29 Oct Why the Atomo (ASX:AT1) share price is flying 9% higher today
Motley Fool talks about our share price gain following TGA approval of our COVID-19 rapid antigen test. Read the full article > ...
29 Oct Atomo Diagnostics (ASX:AT1) gets TGA approval for 15-minute COVID-19 test
The Market Herald discusses the TGA approval for our COVID-19 rapid antigen test. Read the full article > ...
29 Oct Atomo’s COVID-19 nasal swab test gets green light from TGA
This Business News Australia discusses the benefits of our COVID-19 and the convenience of the 15-minute test. Read the full article > ...
02 Oct Atomo gains rights to rapid COVID-19 diagnostic
An article by Biotech Dispatch on our expanded partnership with Access Bio to launch a rapid COVID-19 antigen test in Australia, New Zealand and India. Read the full article > ...
02 Oct “Game changing” deal for Aussie biotech Atomo
Our MD, John Kelly sat down with Ausbiz to discuss our rapid antigen test deal with Access Bio which will enable screening for COVID-19 acute infection and exposure at the same time. Watch the Video ...
30 Sep DIVOC Labs to sell Atomo’s COVID-19 rapid antibody test in India
An article by Biotech Dispatch on our agreement with DIVOC labs to launch our rapid COVID-19 antibody test in India. Read the full article > ...
30 Sep Why the Atomo (ASX:AT1) share price is moving higher today
An article by Motley Fool on our expanded a partnership with Access Bio to launch a rapid COVID-19 antigen test in Australia, New Zealand and India. Read the full article > ...
30 Sep Atomo (ASX:AT1) share price rockets 10% on new agreement
An article by Motley Fool on our agreement with DIVOC labs to launch our rapid COVID-19 antibody test in India. Read the full article > ...
09 Sep COVID has opened up potentially lucrative opportunities for these Aussie microcaps
Atomo is mentioned in this Stockhead article as one of the Aussie companies involved in the efforts against COVID-19. Read the full article > ...
01 Sep Aussie biotechs join crusade for COVID-19 cure
An article by Stockhead talks about our FY20 results and our COVID-19 antibody tests. Read the full article > ...
31 Aug Atomo Diagnostics’ (ASX:AT1) revenue soars 900pc amid COVID-19 demand
Medical diagnostics company Atomo Diagnostics (AT1) has seen its revenue jump nearly 900 per cent over FY20 as demand for COVID-19 antibody tests skyrockets. Read the full article > ...
31 Aug The world’s best test
An interview with Atomo MD, John Kelly on our FY20 results and strong uplift in revenues. Watch the full interview > ...
- 1
- 2